54 108 54 108 (Temozolomide 250 mg)
Pill with imprint 54 108 54 108 is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Roxane Laboratories, Inc.
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 108 54 108
Temozolomide
- Imprint
- 54 108 54 108
- Strength
- 250 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roxane Laboratories, Inc.
- National Drug Code (NDC)
- 00054-0325 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
sodium starch glycolate type A potato,
tartaric acid,
magnesium stearate,
gelatin,
titanium dioxide,
ferrosoferric oxide,
ferric oxide red,
alcohol,
ferric oxide yellow,
polyethylene glycol,
shellac,
isobutyl alcohol
Note: Inactive ingredients may vary.
More about temozolomide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (8)
- Drug images
- Pricing & coupons
- En español
- Drug class: alkylating agents
Patient resources
- Drug Information
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.